Anodyne Nanotech
Boston
About Anodyne Nanotech
Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs. Its first practical and cost-effective platform, Hero Patch, delivers clinically meaningful doses of macromolecules such as monoclonal antibodies or small molecules for fast and sustained delivery. The company was founded in 2019 by Jake Lombardo, Konstantinos Tzortzakis, and Hojatollah Rezaei Nejad.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.2M
- Funding stage: Seed
- Last round: Seed (May 2021)
- Website: theheropatch.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/anodyne-nanotech-58871 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.